tanshinone has been researched along with Diabetes Mellitus in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guan, YB; Li, L; Wu, Q; Zhang, KJ; Zhou, Y | 1 |
| Liu, Q; Wang, J; Wei, F; Xie, X; Yu, Y; Zhang, M | 1 |
| Cai, K; Duan, JA; Liu, F; Su, SL; Xu, Z; Zhu, Y | 1 |
3 other study(ies) available for tanshinone and Diabetes Mellitus
| Article | Year |
|---|---|
Tanshinone IIA mediates protection from diabetes kidney disease by inhibiting oxidative stress induced pyroptosis.
Topics: Animals; Diabetes Mellitus; Diabetic Nephropathies; Endothelial Cells; Glucose; Humans; Inflammasomes; Mice; Mice, Inbred Strains; NLR Family, Pyrin Domain-Containing 3 Protein; Oxidative Stress; Pyroptosis; Reactive Oxygen Species | 2023 |
Integrated serum pharmacochemistry and serum pharmacology to investigate the active components and mechanism of Bushen Huoxue Prescription in the treatment of diabetic retinopathy.
Topics: Diabetes Mellitus; Diabetic Retinopathy; Humans; Vascular Endothelial Growth Factor A | 2023 |
Salvianolic acid B and tanshinone IIA synergistically improve early diabetic nephropathy through regulating PI3K/Akt/NF-κB signaling pathway.
Topics: Animals; Diabetes Mellitus; Diabetic Nephropathies; Glucose; Inflammation; Nephritis; NF-kappa B; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Signal Transduction | 2024 |